2019
DOI: 10.3390/ijms20020416
|View full text |Cite
|
Sign up to set email alerts
|

A New Approach for Improving the Antibacterial and Tumor Cytotoxic Activities of Pipemidic Acid by Including It in Trimethyl-β-cyclodextrin

Abstract: Pipemidic acid (HPPA) is a quinolone antibacterial agent used mostly to treat gram-negative infections of the urinary tract, but its therapeutic use is limited because of its low solubility. Thus, to improve drug solubility, natural cyclodextrins (CDs) are used for their ability of including guest molecules within their cavities. The aim of this work was to evaluate the antibacterial activity and the preliminary anticancer activity of HPPA included into Heptakis (2,3,6-tri-O-methyl)-β-cyclodextrin (TRIMEB) as … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(17 citation statements)
references
References 46 publications
0
17
0
Order By: Relevance
“…[32,33]. The enhancement of the cytotoxic activity on various cell lines of anti-cancer compounds was proven when the drugs were associated with modified cyclodextrins, namely with Heptakis(2,6-di-O-methyl)-β-cyclodextrin (CD 2) for melanoma cell lines [34] and Heptakis(2,3,6-tri-O-methyl)β-cyclodextrin (CD 3) for hepatoblastoma and breast adenocarcinoma cell lines [35]. However, physicochemical determinations have revealed an important difference between the inclusion complexes of anti-cancer molecules with the two modified cyclodextrins.…”
Section: Resultsmentioning
confidence: 99%
“…[32,33]. The enhancement of the cytotoxic activity on various cell lines of anti-cancer compounds was proven when the drugs were associated with modified cyclodextrins, namely with Heptakis(2,6-di-O-methyl)-β-cyclodextrin (CD 2) for melanoma cell lines [34] and Heptakis(2,3,6-tri-O-methyl)β-cyclodextrin (CD 3) for hepatoblastoma and breast adenocarcinoma cell lines [35]. However, physicochemical determinations have revealed an important difference between the inclusion complexes of anti-cancer molecules with the two modified cyclodextrins.…”
Section: Resultsmentioning
confidence: 99%
“…The UATR-FTIR spectrum of TM-β-CD shows the characteristic peaks of CD at 2929 cm −1 corresponding to symmetric and asymmetric C-H stretching vibration from CH 2 , at 1365 cm −1 assigned to C-H bending from CH 2 , at 1016 cm −1 due to C-C-O stretching vibration. Moreover, characteristic bands are identified in the spectral region 1076-1022 cm −1 attributed to C-O-C stretching vibrations [10,40]. The broad band placed in 3500-3300 cm −1 region (O-H stretching vibration), characteristic for DM-β-CD was not observed in the TM-β-CD spectrum due to the methylation of the OH moieties.…”
Section: Ftir Spectroscopymentioning
confidence: 93%
“…The zone of inhibition (ZOI) values across the discs and wells were recorded using a Vernier caliper [ 35 ]. In addition, the IC 50 values and log IC 50 record (concentrations that can eliminate fifty percent of cell viability) for the specific compound were calculated in GraphPad Prism using nonlinear dose-response modeling., following Lavorgna et al [ 36 ].…”
Section: Methodsmentioning
confidence: 99%